Explainers
Tangled stories and trends that make headlines, but are sometimes hard to get a grasp on. Hop in to learn more about the world around us.

iNCOVACC: All You Need to Know About India’s First Intranasal COVID-19 Vaccine

© AP Photo / Mahesh Kumar AAn employee of Bharat Biotech speaks on a mobile while leaving for home on the outskirts of Hyderabad, India, Saturday, Jan. 9, 2021.
An employee of Bharat Biotech speaks on a mobile while leaving for home on the outskirts of Hyderabad, India, Saturday, Jan. 9, 2021. - Sputnik India, 1920, 27.01.2023
Subscribe
Bharat Biotech rolled out its first nasal vaccine against Covid-19 on India's 74th Republic Day.
India has launched the first-of-its-kind intranasal COVID-19 vaccine in the country called iNCOVACC.
Bharat Biotech’s vaccine was developed in association with the University of Washington. Early studies showed that nasal delivery of this vaccine creates a strong immune response throughout the body.
Here are some interesting facts about the vaccine:
The intranasal vaccine can be used as a primary and booster dose for adults;
The vaccine costs INR 800 ($10.50) in India at private pharmacies and INR 325 ($4) through the government. Its manufacturer, Bharat Biotech, said that it was designed to be economical and is targeted at low- and middle-income countries;
iNCOVACC is stable at 2-8°C and can be stored in a household refrigerator;
Experts say iNCOVACC's delivery mechanism can generate immunity in the mucosal membrane (in the nose and mouth) and better protect against COVID infection, the first site of infection;
China likewise approved an inhalable COVID vaccine Convidecia Air last September administered in the form of a spray developed by CanSino Biologics Inc.
Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала